Drug
RNS60 clinical trials
Also written RNS60.
- studies test it
- 13
- open now
- 0
- in phase 3
- 0
- first study started
- 2010
How studies write it
Studies that test it under each name
Development codes
- RNS60
- 12
Studies by the year they started
9 studies that test it; most in 2015 (3)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 3 |
| 2017 | 1 |
| 2021 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 2
Revalesio Corporation (11) · Mario Negri Institute for Pharmacological Research (1) · Sabrina Paganoni, M.D. (1)
Studies
Open first, then newest update. How each study uses RNS60 is read from its arms, and is right about nine times in ten.
Testing it · 13
- Nebulized RNS60 for the Treatment of Amyotrophic Lateral SclerosisWithdrawnPhase 2Revalesio CorporationNCT02988297Written as RNS60
- Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular ThrombectomyCompletedPhase 2Revalesio CorporationNCT04693715Written as RNS60
- The Effect of RNS60 on ALS BiomarkersCompletedPhase 2Mario Negri Institute for Pharmacological ResearchNCT03456882Written as RNS60
- A Pilot Study of RNS60 in Amyotrophic Lateral Sclerosis (ALS)CompletedPhase 1Sabrina Paganoni, M.D.NCT02525471Written as RNS60
- Effect of RNS60 on the Late Phase Asthmatic Response to Allergen ChallengeCompletedPhase 2Revalesio CorporationNCT02422121Written as RNS60
- Pilot Study of RNS60 in Allergen-induced BronchoconstrictionWithdrawnPhase 2Revalesio CorporationNCT02497222Written as RNS60
- Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple SclerosisWithdrawnPhase 2Revalesio CorporationNCT01714089Written as RNS60 125 ml
- Systemic Bioactivity of Inhaled Nebulized RNS60CompletedPhase 1Revalesio CorporationNCT02490865Written as RNS60
- Study of RNS60 on Pain and Function After Knee Anterior Cruciate Ligament SurgeryWithdrawnPhase 2Revalesio CorporationNCT01922427Written as RNS60
- Study of RNS60 on Pain and Function After Hip Labral RepairWithdrawnPhase 2Revalesio CorporationNCT02005523Written as RNS60
- Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate AsthmaCompletedPhase 1Revalesio CorporationNCT01511302Written as RNS60
- Safety Study of Nebulized RNS60 to Treat Asthma.CompletedPhase 1Revalesio CorporationNCT01057498Written as RNS60
- Safety and Tolerability of RNS60 Given by IV to Healthy SubjectsCompletedPhase 1Revalesio CorporationNCT01264783Written as RNS60
Codes
What other systems call RNS60 · ClinicalTrials.gg INT000937
- MeSH (NLM) C000627108RNS60One source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000627108 | RNS60 | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.